Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration
Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration
Active, not recruiting · NCT02286089 · Registry updated 2026-07-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration | age-related macular degeneration, eye disorder, macular degeneration, retinal degeneration, retinal disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-07-27 | NCT02286089 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hoffmann-La Roche | 280 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cincinnati Eye Institute | Cincinnati | United States | 22 |
| Hadassah Medical Center | Jerusalem | Israel | 50 |
| Kaplan Medical Center | Rehovot | Israel | 10 |
| Mid Atlantic Retina | Philadelphia | United States | 7 |
| Rabin Medical Center | Petah Tikva | Israel | 62 |
| Tel Aviv Sourasky Medical Center | Tel Aviv | Israel | 60 |
| West Coast Retina Medical Group | San Francisco | United States | 3 |